June 21, 2007Open Access
View Full PaperChemotherapy Is Associated With Improved Survival in Adult Patients With Primary Extremity Synovial Sarcoma
Structured PICO
Does ifosfamide-based chemotherapy improve disease-specific survival in adult patients with high-risk, primary, extremity, synovial sarcoma?
P
Population
Adult patients with high-risk, primary, extremity, synovial sarcoma
I
Intervention
Ifosfamide-based chemotherapy
O
Outcome
Disease-specific survival (DSS)hard clinical
Ifosfamide-based chemotherapy is associated with improved disease-specific survival in adult patients with high-risk primary extremity synovial sarcoma.
Abstract
Ifosfamide-based chemotherapy was associated with an improved DSS in adult patients with high-risk, primary, extremity, synovial sarcoma and should be considered in the treatment of such patients.